ITI Pharma and Healthcare Fund Direct - Growth
ITI Pharma and Healthcare Fund Direct - Growth: Mutual Fund Overview
ITI Pharma and Healthcare Fund Direct - Growth is an Sectoral-Pharma mutual fund with over 4.37 years of performance history. The scheme manages an AUM of ₹221.77 Cr and has a NAV of ₹15.9504. It is rated '2' stars by analysts. Investors can begin a SIP with as little as ₹500.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of -6.22%.
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return -6.22% at 24 Mar 2026 03:48 PM
Fund Details
NAV 15.9504
Sub-Type Sectoral-Pharma
Rating 2
Min. SIP Amount ₹500.0
Fund Age(Year) 4.37
Fund Size(in Crores) 221.77
Fund Performance
1 Month -4.66%
3 Month -7.31%
6 Month -9.72%
1 Year -6.22%
3 Year 20.69%
5 Year 0.0%
Know This Fund
As on 24 Mar 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (0%) Market Cap Top Sectors Top Holding
Debt & Others (100%) Sector Allocation Reverse Repo 84.68 Net Receivables 0.09 Repo 13.61 Debt Credit Ratings Cash & Call Money 98.37 SOV 1.63 Debt Category Others 98.37 Reserve Bank of India 1.63
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Retirement Fund - The 50s Plus - Debt Plan Regular-Growth Ret 1M -0.37% Ret 1Y 3.47% Ret 3Y 5.02% Ret 5Y 4.06%
Equity, Flexi Cap funds Aditya Birla Sun Life Retirement Fund - The 50s Plus - Debt Plan Regular-IDCW Ret 1M -0.37% Ret 1Y 3.47% Ret 3Y 5.02% Ret 5Y 4.06%
Equity, Flexi Cap funds Aditya Birla Sun Life Retirement Fund - The 50s Plus - Debt Plan Regular-IDCW Reinvestment Ret 1M -0.37% Ret 1Y 3.47% Ret 3Y 5.02% Ret 5Y 4.06%
Equity, Flexi Cap funds Aditya Birla Sun Life Short Term Fund Regular-Growth Ret 1M -0.18% Ret 1Y 6.33% Ret 3Y 7.17% Ret 5Y 6.2%
Equity, Flexi Cap funds Aditya Birla Sun Life Short Term Fund Regular-IDCW Ret 1M -0.18% Ret 1Y 6.33% Ret 3Y 7.17% Ret 5Y 6.2%
Equity, Flexi Cap funds Aditya Birla Sun Life Short Term Fund Regular-IDCW Quarterly Ret 1M -0.18% Ret 1Y 6.33% Ret 3Y 7.17% Ret 5Y 6.2%
Equity, Flexi Cap funds Aditya Birla Sun Life Short Term Fund Regular-IDCW Reinvestment Ret 1M -0.18% Ret 1Y 6.33% Ret 3Y 7.17% Ret 5Y 6.2%
Equity, Flexi Cap funds Axis Short Duration Fund Regular-Bonus Ret 1M -0.15% Ret 1Y 6.7% Ret 3Y 7.3% Ret 5Y 6.11%
Equity, Flexi Cap funds Axis Short Duration Fund Regular-Growth Ret 1M -0.15% Ret 1Y 6.7% Ret 3Y 7.3% Ret 5Y 6.11%
Equity, Flexi Cap funds Axis Short Duration Fund Regular-IDCW Monthly Payout Ret 1M -0.15% Ret 1Y 6.7% Ret 3Y 7.3% Ret 5Y 6.11%
Equity, Flexi Cap funds Axis Short Duration Fund Regular-IDCW Monthly Reinvestment Ret 1M -0.15% Ret 1Y 6.7% Ret 3Y 7.3% Ret 5Y 6.11%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 0.47%
Exit Load 0.5%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Rajesh Bhatia
Education Mr. Bhatia has done B.Com, ACMA and CFA
Experience Prior to joining ITI Mutual Fund, he was associated with The Investment Trust Of India Ltd, Simto Investment Company Ltd, ProAlpha Systematic Capital, Heritage India Advisors Ltd and Reliance Capital Asset Management Ltd
Dhimant Shah
Education Mr. Shah is a B.Com (H) and Chartered Accountant.
Experience Prior to joining ITI Mutual Fund, he has worked with Principal Mutual Fund, HSBC AMC, Reliance Mutual Fund, ASK Raymond James Securities Pvt. Ltd. and IL&FS AMC. Senior Analyst from April 1997 to August 2003.
Rohan Korde
Education Mr. Korde is a Masters in Management Studies (Finance), Bachelor of Commerce
Experience Prior to joining ITI Mutual Fund, he has worked with BOB Capital Markets as Vice President
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 13
Date of Incorporation 2021-11-08
Total AUM 10936.13
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Take Your Next Step
ITI Pharma and Healthcare Fund Direct - Growth FAQs
How to invest in ITI Pharma and Healthcare Fund Direct - Growth?
Investing in ITI Pharma and Healthcare Fund Direct - Growth through Motilal Oswal is simple and completely online. You just need to follow the step-by-step process below to get started in a few minutes.
- Log in to your Motilal Oswal account via the app or website
- Go to the Mutual Funds section
- Search for ITI Pharma and Healthcare Fund Direct - Growth in the search bar
- Select your preferred investment mode – Lumpsum or SIP
- Enter investment details such as amount and linked bank account
- Complete your KYC, if not already done
- Review and confirm details including fund name, plan type, amount, and bank account
- Make the payment using Net Banking, UPI, or other available options
- Receive transaction confirmation via email or SMS
What is the expense ratio of ITI Pharma and Healthcare Fund Direct - Growth?
The term expense ratio for ITI Pharma and Healthcare Fund Direct - Growth or any other mutual fund is the annual fee charged by the fund house for managing your investment scheme. The expense ratio of ITI Pharma and Healthcare Fund Direct - Growth is 0.47% as of 24 Mar 2026.
What is the NAV of ITI Pharma and Healthcare Fund Direct - Growth?
The NAV of ITI Pharma and Healthcare Fund Direct - Growth is ₹15.9504 as of 24 Mar 2026.
What is the AUM of ITI Pharma and Healthcare Fund Direct - Growth?
The AUM (Assets Under Management) of ITI Pharma and Healthcare Fund Direct - Growth is the total value of assets managed by the fund at a given time, which is updated regularly. The AUM of ITI Pharma and Healthcare Fund Direct - Growth is ₹221.77 Cr as of 24 Mar 2026.
What is the PE and PB ratio of ITI Pharma and Healthcare Fund Direct - Growth?
The PE ratio of ITI Pharma and Healthcare Fund Direct - Growth shows how much investors are paying for the fund's underlying earnings, while the PB ratio indicates how the fund's holdings are valued compared to their book value.
Can I invest in SIP and Lump Sum in ITI Pharma and Healthcare Fund Direct - Growth?
Yes, you can invest in ITI Pharma and Healthcare Fund Direct - Growth through both SIP (Systematic Investment Plan) and lump sum options, depending on your investment preference and financial goals.
What is the return of ITI Pharma and Healthcare Fund Direct - Growth in the last 5 years?
The return of ITI Pharma and Healthcare Fund Direct - Growth in the last 5 years is 0.0%.
What is the minimum SIP investment required in ITI Pharma and Healthcare Fund Direct - Growth?
The minimum SIP investment in ITI Pharma and Healthcare Fund Direct - Growth depends on the fund's scheme rules and usually starts at a small amount. For ITI Pharma and Healthcare Fund Direct - Growth, the minimum SIP amount is ₹500.0.
What is the current NAV of ITI Pharma and Healthcare Fund Direct - Growth?
The NAV of ITI Pharma and Healthcare Fund Direct - Growth, as of 24 Mar 2026, is ₹15.9504.
Who manages the ITI Pharma and Healthcare Fund Direct - Growth?
The fund managers responsible for ITI Pharma and Healthcare Fund Direct - Growth are:
- Rajesh Bhatia
- Dhimant Shah
- Rohan Korde